Back to Journals » OncoTargets and Therapy » Volume 6

Pulmonary adenocarcinoma with osseous metaplasia: a rare occurrence possibly associated with early stage?

Authors Zhang Q, Yin L, Li B, Meng R, Dao R, Hu S, Qiu X

Received 7 July 2013

Accepted for publication 29 September 2013

Published 11 November 2013 Volume 2013:6 Pages 1631—1634

DOI https://doi.org/10.2147/OTT.S48195

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 5



Qingfu Zhang,1 Liying Yin,2 Bo Li,3 Rui Meng,4 Runa Dao,1 Suxiang Hu,3 Xueshan Qiu1

1Department of Pathology, The First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, 2Department of Pathology, No 5 People's Hospital, Dalian, 3Shengjing Hospital of China Medical University, Shenyang, 4Department of Gerontology, Aerospace Central Hospital, Beijing, People's Republic of China

Abstract: Adenocarcinoma is the most common type of malignant pulmonary tumor, but osseous metaplasia of this tumor is extremely rare. To date, only 21 cases have been reported in the literature worldwide. Here, we report a case of primary pulmonary adenocarcinoma with benign osseous stromal metaplasia in a 60-year-old woman and discuss the pathogenesis of intratumoral ossification and review the relevant literature. We found that pulmonary adenocarcinoma with osseous metaplasia may be more likely to occur in early tumor stages.

Keywords: pulmonary adenocarcinoma, immunohistochemistry, osseous metaplasia

Creative Commons License © 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.